188 related articles for article (PubMed ID: 33414055)
21. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
[TBL] [Abstract][Full Text] [Related]
23. Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis.
Kostic Peric J; Cirkovic A; Srzentic Drazilov S; Samardzic N; Skodric Trifunovic V; Jovanovic D; Pavlovic S
Radiol Oncol; 2023 Mar; 57(1):12-19. PubMed ID: 36942904
[TBL] [Abstract][Full Text] [Related]
24. Thymic carcinoma: involvement of great vessels indicates poor prognosis.
Tseng YL; Wang ST; Wu MH; Lin MY; Lai WW; Cheng FF
Ann Thorac Surg; 2003 Oct; 76(4):1041-5. PubMed ID: 14529981
[TBL] [Abstract][Full Text] [Related]
25. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
[TBL] [Abstract][Full Text] [Related]
26. Thymic tumors: relevant molecular data in the clinic.
Girard N
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S291-5. PubMed ID: 20859122
[TBL] [Abstract][Full Text] [Related]
27. Mutations of epigenetic regulatory genes are common in thymic carcinomas.
Wang Y; Thomas A; Lau C; Rajan A; Zhu Y; Killian JK; Petrini I; Pham T; Morrow B; Zhong X; Meltzer PS; Giaccone G
Sci Rep; 2014 Dec; 4():7336. PubMed ID: 25482724
[TBL] [Abstract][Full Text] [Related]
28. Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors.
Valdivia D; Cheufou D; Fels B; Puhlvers S; Mardanzai K; Zaatar M; Weinreich G; Taube C; Theegarten D; Stuschke M; Schuler M; Stamatis G; Hegedus B; Aigner C
Pathol Oncol Res; 2021; 27():629993. PubMed ID: 34257595
[TBL] [Abstract][Full Text] [Related]
29. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the EGFR gene and its downstream signaling pathway in thymic carcinoma patients from a Chinese Han population.
Zhan P; Chen X; Wu XY; Hou ZB; Qian Q; Zhang Y; Zou J; Zhang YQ; Wan MY; Wang JD; Yu LK; Xie HY
Clin Respir J; 2018 Feb; 12(2):601-607. PubMed ID: 27731926
[TBL] [Abstract][Full Text] [Related]
31. Systemic treatment of advanced thymic malignancies.
Kelly RJ
Am Soc Clin Oncol Educ Book; 2014; ():e367-73. PubMed ID: 24857125
[TBL] [Abstract][Full Text] [Related]
32. Aberrant methylation: common in thymic carcinomas, rare in thymomas.
Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H
Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
[TBL] [Abstract][Full Text] [Related]
34. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
[TBL] [Abstract][Full Text] [Related]
35. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma.
Hosaka Y; Tsuchida M; Toyabe S; Umezu H; Eimoto T; Hayashi J
Ann Thorac Surg; 2010 Mar; 89(3):912-7. PubMed ID: 20172153
[TBL] [Abstract][Full Text] [Related]
36. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas.
Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ
Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
Ma YQ; Zhang C; Cui WL; Gulinaer A; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):820-4. PubMed ID: 22336207
[TBL] [Abstract][Full Text] [Related]
38. Sorafenib efficacy in thymic carcinomas seems not to require c-KIT or PDGFR-alpha mutations.
Pagano M; Sierra NM; Panebianco M; Rossi G; Gnoni R; Bisagni G; Boni C
Anticancer Res; 2014 Sep; 34(9):5105-10. PubMed ID: 25202099
[TBL] [Abstract][Full Text] [Related]
39. Thymic epithelial tumors: a clinicopathologic study of 249 cases from a single institution.
Su XY; Wu WL; Liu N; Zhang SF; Li GD
Int J Clin Exp Pathol; 2014; 7(11):7760-7. PubMed ID: 25550813
[TBL] [Abstract][Full Text] [Related]
40. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.
Mimae T; Tsuta K; Kondo T; Nitta H; Grogan TM; Okada M; Asamura H; Tsuda H
Ann Oncol; 2012 Dec; 23(12):3129-3137. PubMed ID: 22700994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
